Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
+0.170 (11.33%)
At close: Mar 30, 2026
Revium Rx. Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Cash & Equivalents | 0.92 | 1.68 | 3.27 | 1.19 | 0.43 | 0 |
Short-Term Investments | 1.22 | 1.03 | 2.01 | 0.01 | - | - |
Cash & Short-Term Investments | 2.14 | 2.71 | 5.28 | 1.19 | 0.43 | 0 |
Cash Growth | -56.62% | -48.65% | 342.50% | 180.05% | 54938.76% | -95.14% |
Accounts Receivable | - | - | - | - | - | 0.02 |
Other Receivables | - | 0.07 | 0.04 | 0.15 | 0.01 | - |
Receivables | - | 0.07 | 0.04 | 0.15 | 0.01 | 0.02 |
Inventory | - | - | - | - | - | 0.11 |
Prepaid Expenses | - | 0.28 | 0.17 | 0.21 | 0.02 | 0 |
Other Current Assets | 0.34 | 0.04 | 0.02 | 0 | - | - |
Total Current Assets | 2.48 | 3.1 | 5.52 | 1.56 | 0.46 | 0.13 |
Property, Plant & Equipment | 0.2 | 0.13 | 0.01 | 0 | 0 | 0 |
Goodwill | 2.58 | 2.58 | 11.41 | - | - | 0.3 |
Other Intangible Assets | 2.5 | 2.5 | 3.34 | - | - | 0.58 |
Long-Term Deferred Charges | - | - | - | - | - | 0.38 |
Other Long-Term Assets | - | - | - | - | - | -0 |
Total Assets | 7.76 | 8.3 | 20.28 | 1.56 | 0.46 | 1.39 |
Accounts Payable | 0.23 | 0.16 | 0.14 | 0.05 | 0.05 | 0.32 |
Accrued Expenses | - | 0.56 | 0.21 | 0.1 | - | - |
Short-Term Debt | 0 | 0 | 0 | - | 0 | - |
Current Portion of Leases | 0.08 | 0.06 | - | - | - | - |
Other Current Liabilities | 0.64 | 0.02 | 0 | 0.01 | 0.02 | - |
Total Current Liabilities | 1.53 | 1.37 | 0.58 | 0.17 | 0.07 | 0.32 |
Long-Term Debt | - | - | - | - | - | 0.2 |
Long-Term Leases | 0.07 | 0.05 | - | - | - | - |
Total Liabilities | 1.6 | 1.42 | 0.58 | 0.17 | 0.07 | 0.52 |
Common Stock | 0.06 | 0.06 | 0.06 | 0 | 0.03 | 0.02 |
Additional Paid-In Capital | 31.78 | 31.78 | 30.39 | 3.31 | 5 | 0.88 |
Retained Earnings | -25.69 | -24.96 | -11.51 | -1.92 | -4.64 | -0.03 |
Total Common Equity | 6.16 | 6.88 | 18.94 | 1.39 | 0.39 | 0.87 |
Minority Interest | - | - | 0.77 | - | - | - |
Shareholders' Equity | 6.16 | 6.88 | 19.71 | 1.39 | 0.39 | 0.87 |
Total Liabilities & Equity | 7.76 | 8.3 | 20.28 | 1.56 | 0.46 | 1.39 |
Total Debt | 0.15 | 0.1 | 0 | - | 0 | 0.2 |
Net Cash (Debt) | 1.99 | 2.61 | 5.28 | 1.19 | 0.43 | -0.2 |
Net Cash Growth | -59.70% | -50.57% | 342.41% | 180.71% | - | - |
Net Cash Per Share | 0.03 | 0.04 | 0.21 | 0.04 | 0.02 | -3.42 |
Filing Date Shares Outstanding | 60.73 | 61.32 | 60.73 | 57.93 | 28.11 | 0.07 |
Total Common Shares Outstanding | 60.73 | 60.73 | 60.73 | 34.76 | 28.11 | 0.07 |
Working Capital | 0.95 | 1.73 | 4.94 | 1.39 | 0.39 | -0.19 |
Book Value Per Share | 0.10 | 0.11 | 0.31 | 0.04 | 0.01 | 12.47 |
Tangible Book Value | 1.08 | 1.81 | 4.18 | 1.39 | 0.39 | -0.01 |
Tangible Book Value Per Share | 0.02 | 0.03 | 0.07 | 0.04 | 0.01 | -0.14 |